In our study, MDD patients had no significant alteration in plasma IGFBP-1, IGFBP-3, and IGFBP-5 at baseline, whereas IGFBP-7 was significantly increased compared to controls. This evidence concerns the gene IGFBP3 and major depressive disorder.